Search Results - "Bakker, Daphne S"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy by Ariëns, Lieneke F.M., Bakker, Daphne S., van der Schaft, Jorien, Garritsen, Floor M., Thijs, Judith L., de Bruin-Weller, Marjolein S.

    Published in Therapeutic Advances in Chronic Disease (01-09-2018)
    “…Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. The prevalence of AD is increasing and is currently estimated at 10–20% in…”
    Get full text
    Book Review Journal Article
  8. 8

    Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers by Bakker, Daphne S., Nierkens, Stefan, Knol, Edward F., Giovannone, Barbara, Delemarre, Eveline M., van der Schaft, Jorien, van Wijk, Femke, de Bruin-Weller, Marjolein S., Drylewicz, Julia, Thijs, Judith L.

    Published in Journal of allergy and clinical immunology (01-01-2021)
    “…Atopic dermatitis (AD) is a highly heterogeneous disease, both clinically and biologically, whereas patients are still being treated according to a…”
    Get full text
    Journal Article
  9. 9

    Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters by Bakker, Daphne S., de Graaf, Marlies, Nierkens, Stefan, Delemarre, Eveline M., Knol, Edward, van Wijk, Femke, de Bruin-Weller, Marjolein S., Drylewicz, Julia, Thijs, Judith L.

    Published in Journal of allergy and clinical immunology (01-01-2022)
    “…Increasing evidence shows that pediatric atopic dermatitis (AD) differs from adult AD on a biologic level. Broad biomarker profiling across a wide range of…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis by Boesjes, Celeste M, van der Gang, Lian F, Bakker, Daphne S, Ten Cate, Tess A, Spekhorst, Lotte S, de Graaf, Marlies, van Dijk, Marijke R, de Bruin-Weller, Marjolein S

    Published in JAMA dermatology (Chicago, Ill.) (01-11-2023)
    “…Since the increased use of dupilumab for atopic dermatitis (AD) in daily practice, several cases have been reported on the development of cutaneous T-cell…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20